ConforMIS,Inc. (NASDAQ:CFMS) Files An 8-K Results of Operations and Financial Condition

ME Staff 8-k
-
0

ConforMIS,Inc. (NASDAQ:CFMS) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition

ConforMIS,Inc. (the “Company”) announces that its gross profit is expected to be approximately $28.8million, or approximately 37% of revenue, for the year ended December31, 2017, as compared to $26.7million, or 33% of revenue, for year ended 2016. In addition, the Company announces that it expects gross margin for the quarter ended December31, 2017 to be approximately 42%. Total debt is expected to be approximately $30 million, and cash used (including cash equivalents and investments) for the quarter ended December31, 2017 is projected to be approximately $9.3 million. The Company’s cash, cash equivalents and investments as of December31, 2017 are projected to be approximately $45.2 million, as compared to $65.5 million as of December31, 2016.

The forgoing financial data as of the quarter and year ended December31, 2017 are preliminary and are based on information available to management as of the date of this Current Report on Form8-K. These financial data are subject to completion of the Company’s financial statements as of and for the quarter and year ended December 31, 2017, and have not been audited by the Company’s independent registered public accountants. These results could change as a result of further review. The Company will report its full financial results for the quarter and the year ended December 31, 2017 on February7, 2018.

The information furnished under this Item 2.02 shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.

Item 7.01 Regulation FD

The information in Item 2.02 to this Current Report on Form 8-K is hereby incorporated by reference.


About ConforMIS,Inc. (NASDAQ:CFMS)

ConforMIS, Inc. is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee. Its iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. The Company markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong.